Relcovaptan Explained

Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1a subtype.[1] It has shown positive initial results for the treatment of Raynaud's disease and dysmenorrhoea, and as a tocolytic,[2] although it is not yet approved for clinical use.

Notes and References

  1. Lemmens-Gruber R, Kamyar M . Vasopressin antagonists . Cellular and Molecular Life Sciences . 63 . 15 . 1766–79 . August 2006 . 16794787 . 10.1007/s00018-006-6054-2 . 30709102 . 11136164 .
  2. Decaux G, Soupart A, Vassart G . Non-peptide arginine-vasopressin antagonists: the vaptans . Lancet . 371 . 9624 . 1624–32 . May 2008 . 18468546 . 10.1016/S0140-6736(08)60695-9 . 1245079 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Relcovaptan".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.